These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27233152)

  • 1. Improvements with sublingual house dust mite immunotherapy in allergic rhinitis.
    Lipworth B
    J Allergy Clin Immunol; 2016 Aug; 138(2):634-5. PubMed ID: 27233152
    [No Abstract]   [Full Text] [Related]  

  • 2. Early increase in serum specific IgG2 upon allergen immunotherapy with a 300 IR sublingual house dust mite tablet.
    Berjont N; Floch VVB; O'Hehir RE; Canonica WG; van Zelm MC; Batard T; Mascarell L
    Allergy; 2023 Jul; 78(7):2040-2043. PubMed ID: 36809660
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis.
    Demoly P; Kleine-Tebbe J; Rehm D
    Allergy; 2017 Oct; 72(10):1576-1578. PubMed ID: 28273339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute systemic reactions to sublingual immunotherapy for house dust mite.
    Janssens NS; van Ouwerkerk L; Gerth van Wijk R; Karim F
    Allergy; 2020 Nov; 75(11):2962-2963. PubMed ID: 32449962
    [No Abstract]   [Full Text] [Related]  

  • 5. A Three-Year Course of House Dust Mite Sublingual Immunotherapy Appears Effective in Controlling the Symptoms of Allergic Rhinitis.
    Novakova SM; Novakova PI; Yakovliev PH; Staevska MT; Mateva NG; Dimcheva TD; Peichev JL
    Am J Rhinol Allergy; 2018 May; 32(3):147-152. PubMed ID: 29649893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Odactra--sublingual immunotherapy for house dust mite-induced allergic rhinitis.
    Med Lett Drugs Ther; 2018 Feb; 60(1541):37-39. PubMed ID: 29485977
    [No Abstract]   [Full Text] [Related]  

  • 7. Switching from subcutaneous to sublingual immunotherapy during the maintenance phase in patients with house dust mite allergy.
    Kiatiwat P; Sangasapaviliya A; Pradubpongsa P; Sangkanjanavanich S; Chiewchalermsri C; Jacquet A; Jaisupa N; Jindarat S; Boonpiyathad T; Mitthamsiri W
    Allergy; 2023 Jul; 78(7):2019-2021. PubMed ID: 36754574
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and tolerability of the standardized quality house dust mite sublingual immunotherapy tablet in real life: A noninterventional, open-label study.
    Reiber R; Wolf H; Futschik T; Schwab JA; Hölscher U; Schnitker J; Wüstenberg E
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3221-3223.e5. PubMed ID: 33839345
    [No Abstract]   [Full Text] [Related]  

  • 9. Sublingual immunotherapy (SLIT) for house dust mite - when to take a break?: An unusual reaction to SLIT post vaccinations.
    Gallagher A; Trujillo J
    Ann Allergy Asthma Immunol; 2023 Jun; 130(6):809-810. PubMed ID: 36924938
    [No Abstract]   [Full Text] [Related]  

  • 10. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.
    Nolte H; Maloney J; Nelson HS; Bernstein DI; Lu S; Li Z; Kaur A; Zieglmayer P; Zieglmayer R; Lemell P; Horak F
    J Allergy Clin Immunol; 2015 Jun; 135(6):1494-501.e6. PubMed ID: 25636947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis.
    Bozek A; Ignasiak B; Filipowska B; Jarzab J
    Clin Exp Allergy; 2013 Feb; 43(2):242-8. PubMed ID: 23331565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis.
    Okubo K; Masuyama K; Imai T; Okamiya K; Stage BS; Seitzberg D; Konno A
    J Allergy Clin Immunol; 2017 Jun; 139(6):1840-1848.e10. PubMed ID: 27864024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.
    Bergmann KC; Demoly P; Worm M; Fokkens WJ; Carrillo T; Tabar AI; Nguyen H; Montagut A; Zeldin RK
    J Allergy Clin Immunol; 2014 Jun; 133(6):1608-14.e6. PubMed ID: 24388010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.
    Yonekura S; Okamoto Y; Sakurai D; Horiguchi S; Hanazawa T; Nakano A; Kudou F; Nakamaru Y; Honda K; Hoshioka A; Shimojo N; Kohno Y
    Allergol Int; 2010 Dec; 59(4):381-8. PubMed ID: 20864799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tonsillectomy on the efficacy of house dust mite sublingual immunotherapy.
    Refaat M; Ashour ZA; Farres MN; Eissa AM; Elsayed MM
    Allergol Immunopathol (Madr); 2015; 43(1):108-11. PubMed ID: 24388811
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis.
    Lee JE; Choi YS; Kim MS; Han DH; Rhee CS; Lee CH; Kim DY
    Ann Allergy Asthma Immunol; 2011 Jul; 107(1):79-84. PubMed ID: 21704889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual immunotherapy in patients with house dust mite allergic rhinitis: prospective study of clinical outcomes over a two-year period.
    Soh JY; Thalayasingam M; Ong S; Loo EX; Shek LP; Chao SS
    J Laryngol Otol; 2016 Mar; 130(3):272-7. PubMed ID: 26781592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.
    Nolte H; Bernstein DI; Nelson HS; Kleine-Tebbe J; Sussman GL; Seitzberg D; Rehm D; Kaur A; Li Z; Lu S
    J Allergy Clin Immunol; 2016 Dec; 138(6):1631-1638. PubMed ID: 27521719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.